|
WO2001017965A2
(en)
|
1999-09-07 |
2001-03-15 |
Syngenta Participations Ag |
Cyanopiperidines as pesticides
|
|
PH12000002657B1
(en)
|
1999-10-12 |
2006-02-21 |
Bristol Myers Squibb Co |
C-aryl glucoside SGLT2 inhibitors
|
|
US6515117B2
(en)
|
1999-10-12 |
2003-02-04 |
Bristol-Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
|
FR2801585B1
(fr)
|
1999-11-25 |
2002-02-15 |
Fournier Ind & Sante |
Nouveaux antagonistes des recepteurs de l'ii-8
|
|
WO2002028831A1
(en)
|
2000-10-02 |
2002-04-11 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
FR2824827B1
(fr)
|
2001-05-17 |
2004-02-13 |
Fournier Lab Sa |
Nouveaux derives de 5-phenyl-1h-indole antagoniste des recepteurs de l'interleukine-8
|
|
FR2824826B1
(fr)
|
2001-05-17 |
2003-11-07 |
Fournier Lab Sa |
Nouveaux derives de 5-cyano-1h-indole antagonistes des recepteurs de l'interleukine-8
|
|
WO2003104180A1
(en)
|
2002-06-05 |
2003-12-18 |
Natco Pharma Limited |
Process for the preparation of 4-(4-fluorobenzoyl) butyric acid
|
|
TWI254635B
(en)
|
2002-08-05 |
2006-05-11 |
Yamanouchi Pharma Co Ltd |
Azulene derivative and salt thereof
|
|
ATE510834T1
(de)
|
2003-03-14 |
2011-06-15 |
Astellas Pharma Inc |
C-glykosid-derivate zur behandlung von diabetes
|
|
WO2005092854A1
(en)
|
2004-03-03 |
2005-10-06 |
Eli Lilly And Company |
Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
|
|
EA011158B1
(ru)
|
2004-03-16 |
2009-02-27 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Замещённые глюкопиранозилом бензольные производные, содержащие эти соединения лекарственные средства, их применение и способ их получения
|
|
AR051446A1
(es)
|
2004-09-23 |
2007-01-17 |
Bristol Myers Squibb Co |
Glucosidos de c-arilo como inhibidores selectivos de transportadores de glucosa (sglt2)
|
|
JP2008524162A
(ja)
|
2004-12-16 |
2008-07-10 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
グルコピラノシル置換ベンゼン誘導体、該化合物を含む薬物、その使用及びその製造方法
|
|
TW200637869A
(en)
|
2005-01-28 |
2006-11-01 |
Chugai Pharmaceutical Co Ltd |
The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
|
|
US7723309B2
(en)
|
2005-05-03 |
2010-05-25 |
Boehringer Ingelheim International Gmbh |
Crystalline forms of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((R)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
|
|
UA91546C2
(uk)
|
2005-05-03 |
2010-08-10 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
|
|
JP5175191B2
(ja)
|
2005-08-30 |
2013-04-03 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
グリコピラノシル置換ベンジルベンゼン誘導体、該化合物を含有する医薬品及びその使用と製造方法
|
|
BRPI0615882A2
(pt)
|
2005-09-08 |
2011-05-31 |
Boehringer Ingelheim Int |
formas cristalinas de 1-cloro-4-(beta-d-glicopiranos-1-il)-2-(4-etinil-benzil)- benzeno, métodos para sua preparação e o uso para preparar medicamentos do mesmo
|
|
AR056195A1
(es)
|
2005-09-15 |
2007-09-26 |
Boehringer Ingelheim Int |
Procedimientos para preparar derivados de (etinil-bencil)-benceno sustituidos de glucopiranosilo y compuestos intermedios de los mismos
|
|
AR059489A1
(es)
|
2006-02-15 |
2008-04-09 |
Boehringer Ingelheim Vetmed |
Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
|
|
PE20080697A1
(es)
|
2006-05-03 |
2008-08-05 |
Boehringer Ingelheim Int |
Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
|
|
US8283326B2
(en)
|
2006-10-27 |
2012-10-09 |
Boehringer Ingelheim International Gmbh |
Crystalline form of 4-(beta-D-glucopyranos-1-yl)-1-methyl-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
|
|
AR063569A1
(es)
|
2006-11-06 |
2009-02-04 |
Boehringer Ingelheim Int |
Derivados de benzil- benzonitrilo sustituidos con glucopiranosilo medicamentos que contienen a compuestos de este tipo su uso u procedimiento para su fabricacion
|
|
CL2007003227A1
(es)
|
2006-11-09 |
2008-07-04 |
Boehringer Ingelheim Int |
Composicion farmaceutica que comprende un derivado de benceno sustituido con glucopiranosilo en combinacion con uno o mas agentes terapeuticos; y uso para el tratamiento de diabetes mellitus, obesidad e hiperglucemia entre otras.
|
|
PT2118074E
(pt)
|
2007-02-01 |
2014-03-20 |
Resverlogix Corp |
Compostos para a prevenção e tratamento de doenças cardiovasculares
|
|
EP2178870B1
(en)
|
2007-08-17 |
2018-09-19 |
LG Chem, Ltd. |
Indole and indazole compounds as an inhibitor of cellular necrosis
|
|
KR101605061B1
(ko)
|
2009-05-29 |
2016-03-21 |
라퀄리아 파마 인코포레이티드 |
칼슘 또는 나트륨 채널 차단제로서의 아릴 치환된 카복사미드 유도체
|
|
WO2012025155A1
(en)
|
2010-08-26 |
2012-03-01 |
Novartis Ag |
Hydroxamate-based inhibitors of deacetylases
|
|
US10130632B2
(en)
*
|
2012-11-27 |
2018-11-20 |
Beth Israel Deaconess Medical Center, Inc. |
Methods for treating renal disease
|
|
US9850203B2
(en)
|
2013-09-26 |
2017-12-26 |
Pharmakea, Inc. |
Autotaxin inhibitor compounds
|
|
CN104007258B
(zh)
*
|
2013-09-30 |
2016-07-06 |
中国医学科学院基础医学研究所 |
局灶性节段性肾小球硬化的蛋白标志物
|
|
WO2016029310A1
(en)
|
2014-08-27 |
2016-03-03 |
The Governing Council Of The University Of Toronto |
Cannabinoid type 1 receptor modulators
|
|
BR112017007178A2
(pt)
|
2014-10-08 |
2017-12-19 |
Ass Francaise Contre Les Myopathies |
compostos de aminopiridina úteis como inibidores de prenilação de proteína
|
|
HRP20210472T1
(hr)
|
2015-08-27 |
2021-05-14 |
Pfizer Inc. |
Biciklički kondenzirani heteroarilni ili arilni spojevi kao modulatori irak4
|
|
CN106539843A
(zh)
*
|
2017-01-11 |
2017-03-29 |
刘国勇 |
山竹在制备治疗局灶节段性肾小球硬化药物方面的新用途
|
|
EP3787669A4
(en)
|
2018-04-30 |
2022-03-30 |
The Trustees of Indiana University |
COMPOUNDS FOR MODULATION OF LEVELS OF DDAH AND ADMA AND METHODS OF USE THEM TO TREAT DISEASES
|
|
LT3897833T
(lt)
*
|
2018-12-17 |
2026-04-27 |
Vertex Pharmaceuticals Incorporated |
Apol1 inhibitoriai ir jų panaudojimo būdai
|
|
EP4097083A1
(en)
|
2020-01-29 |
2022-12-07 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of apol1 and methods of using same
|
|
US20210246121A1
(en)
|
2020-02-04 |
2021-08-12 |
Vertex Pharmaceuticals Incorporated |
Solid forms of apol1 inhibitor and methods of using same
|
|
EP4114385A1
(en)
|
2020-03-06 |
2023-01-11 |
Vertex Pharmaceuticals Incorporated |
Methods of treating apol-1 dependent focal segmental glomerulosclerosis
|
|
EP4146633A4
(en)
|
2020-05-07 |
2024-09-25 |
Rambam Med-Tech Ltd. |
COMPOSITION FOR USE IN THE TREATMENT OF A DISEASE ASSOCIATED WITH APOL1
|
|
US20230014907A1
(en)
|
2020-06-12 |
2023-01-19 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of apol1 and methods of using same
|
|
CN115867543A
(zh)
|
2020-06-12 |
2023-03-28 |
弗特克斯药品有限公司 |
Apol1抑制剂的固体形式及其使用方法
|
|
JP2023530271A
(ja)
|
2020-06-12 |
2023-07-14 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Apol1の阻害剤及びこれを使用する方法
|
|
BR112023003423A2
(pt)
|
2020-08-26 |
2023-03-21 |
Vertex Pharma |
Inibidores de apol1 e métodos de uso destes
|
|
KR20240051990A
(ko)
|
2021-08-26 |
2024-04-22 |
버텍스 파마슈티칼스 인코포레이티드 |
스피로트리시클릭 apol1 억제제의 고형분 형태 및 이의 사용 방법
|